6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T38919 | Protein E7(43-62) | Protein E7(43-62) | |
Protein E7(43-62) is a peptide derived from the E7 protein. The peptide spans the 43rd to 62nd amino acid residues and exhibits anti-tumor effects. | |||
TP1595 | Human Papillomavirus (HPV) E7 protein (49-57) | Human Papillomavirus (HPV) E7 protein 49-57 | |
Human Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope. | |||
T8350 | TPCK | Proteasome | |
TPCK is an irreversible inhibitor of chymotrypsin-like proteases that affect cell proliferation, apoptosis, and tumorigenesis | |||
T81369 | Protein E7(43-62) TFA | ||
Protein E7(43-62) TFA, a short peptide derived from the E7 protein spanning amino acid residues 43 to 62, exhibits anti-tumor properties [1]. | |||
TP1515 | HPV16-E711-20 epitope | ||
HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. | |||
T76960 | Verpasep caltespen | ||
Verpasep caltespen (HspE7), a recombinant fusion protein, originates from the Mycobacterium bovis Calmette-Guérin heat shock protein 65 (Hsp65) and is covalently bonded at its C-terminal end to the E7 protein of HPV16. T... |